Caris Life Sciences Incの収益はセグメントまたは地域別にどのように分けられていますか?
Caris Life Sciences Incは収益を上げていますか?
Caris Life Sciences Incに負債はありますか?
Caris Life Sciences Incの発行済株式数は何株ですか?
主要データ
前終値
$20.65
始値
$20.65
当日レンジ
$20.47 - $21.41
52週レンジ
$20.42 - $42.5
取引高
1.4M
平均取引高
2.3M
1株当たり利益(TTM)
-1.56
配当利回り
--
時価総額
$5.8B
CAIとは何ですか?
Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. The company is headquartered in Irving, Texas. The company went IPO on 2025-06-18. The firm develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.